7 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... Note: Systemic antifungals ... candida #mucosal #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... - IDSA Guidelines ... #Candidemia #IDSA ... #candida #candidiasis ... #treatment #fungal
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... depending on their level ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Candida Glabrata
Species of Candida Most Commonly Isolated in Bloodstream Infections
 • Symptomatic mucosal infection is detected
esophageal, & vaginal candidiasis ... with persistent fever ... Treatment: • Exhibits ... time to azole antifungals ... #fungemia #management
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... effects in the treatment ... #valleyfever #management ... #treatment #antifungals ... comparison #table #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... effects in the treatment ... chest/back pain #Antifungal ... Coccidioidomycosis #pharmacology ... #management #treatment
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... lesion(s), the level ... Cytomegalovirus #CMV #IDSA ... #management #opportunistic ... infections #HIVAIDS #pharmacology